Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Moderna, Inc.

NASDAQ: MRNA · Life Sciences · 8 alerts · CIK 1682852

Share price
$215.27Close, Nov 16
Market cap
$87.1B
Shares outstanding
404.62MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Moderna, Inc. filings on SEC EDGAR ↗

6:33 PM ET 8-K
Loan & Debt

Moderna $900M Debt Financing with Ares Capital Corporation

Moderna entered into an amendment to its existing Credit and Guaranty Agreement with Ares Capital Corporation, reducing interest rate margins by 0.75 percentage points and extending the maturity date to November 24, 2031. The amendment also extends the availability period for $900 million in delayed draw term loan commitments through November 2029.

Value
$900M
Counterparty
Ares Capital Corporation
Term
through Nov 2031
4:02 PM ET 8-K
Leadership Change

Moderna Leadership Change

Moderna's Chief Legal Officer, Shannon Thyme Klinger, will retire from the company effective March 31, 2027. Under a transitional services agreement, she will receive $1.63 million in severance plus potential performance bonuses of up to $8 million tied to the outcomes of ongoing litigation with Arbutus, Genevant, Pfizer, and BioNTech.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.